ImmuCell Corporation Inventory Write-down
ImmuCell Corporation (ICCC) reported Inventory Write-down of $406.56 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2025-03-28
- ImmuCell Corporation inventory write-down for the quarter ending 2024-12-31 was $37.84K, a 42.93% decline year-over-year.
- ImmuCell Corporation inventory write-down for the quarter ending 2024-09-30 was -$64.40K.
- ImmuCell Corporation inventory write-down for the quarter ending 2024-06-30 was $316.34K.
- ImmuCell Corporation inventory write-down for the quarter ending 2024-03-31 was $116.78K, a 50.61% decline year-over-year.
- ImmuCell Corporation inventory write-down for fiscal 2024 was $406.56K, a 22.87% decline from fiscal 2023.
- ImmuCell Corporation inventory write-down for fiscal 2023 was $527.13K, a 10.53% decline from fiscal 2022.
- ImmuCell Corporation inventory write-down for fiscal 2022 was $589.20K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $37.84K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$26.56K derived: sum of 2 quarters · filed 2025-03-28 | $289.79K derived: sum of 3 quarters · filed 2025-03-28 | $406.56K 10-K · filed 2025-03-28 | |
| 2024-09-30 | -$64.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $251.94K derived: sum of 2 quarters · filed 2024-11-13 | $368.72K 10-Q · filed 2024-11-13 | $435.04K derived: sum of 4 quarters · filed 2025-03-28 | |
| 2024-06-30 | $316.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $433.12K 10-Q · filed 2024-08-13 | $499.43K derived: sum of 3 quarters · filed 2025-03-28 | ||
| 2024-03-31 | $116.78K 10-Q · filed 2024-05-14 | $183.09K derived: sum of 2 quarters · filed 2025-03-28 | |||
| 2023-12-31 | $66.31K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $527.13K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | $460.82K 10-Q · filed 2023-11-13 | ||||
| 2023-03-31 | $236.46K 10-Q · filed 2024-05-14 | ||||
| 2022-12-31 | $589.20K 10-K · filed 2024-04-01 | $587.62K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |